ATE163294T1 - Die antibiotika ge 37468 a, b und c - Google Patents

Die antibiotika ge 37468 a, b und c

Info

Publication number
ATE163294T1
ATE163294T1 AT94903778T AT94903778T ATE163294T1 AT E163294 T1 ATE163294 T1 AT E163294T1 AT 94903778 T AT94903778 T AT 94903778T AT 94903778 T AT94903778 T AT 94903778T AT E163294 T1 ATE163294 T1 AT E163294T1
Authority
AT
Austria
Prior art keywords
antibiotics
ruminants
swine
poultry
medicaments
Prior art date
Application number
AT94903778T
Other languages
English (en)
Inventor
Sergio Stella
Nicoletta Montanini
Monnier Francis John Le
Luigi Colombo
Enrico Selva
Maurizio Denaro
Original Assignee
Biosearch Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch Italia Spa filed Critical Biosearch Italia Spa
Application granted granted Critical
Publication of ATE163294T1 publication Critical patent/ATE163294T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT94903778T 1992-12-22 1993-12-15 Die antibiotika ge 37468 a, b und c ATE163294T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92121805 1992-12-22

Publications (1)

Publication Number Publication Date
ATE163294T1 true ATE163294T1 (de) 1998-03-15

Family

ID=8210322

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94903778T ATE163294T1 (de) 1992-12-22 1993-12-15 Die antibiotika ge 37468 a, b und c

Country Status (11)

Country Link
EP (1) EP0675900B1 (de)
JP (1) JPH08504782A (de)
KR (1) KR960703410A (de)
AT (1) ATE163294T1 (de)
AU (1) AU679202B2 (de)
CA (1) CA2151616A1 (de)
DE (1) DE69317058T2 (de)
DK (1) DK0675900T3 (de)
ES (1) ES2112517T3 (de)
GR (1) GR3026590T3 (de)
WO (1) WO1994014838A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0402383A3 (en) 2001-11-28 2008-03-28 Vicuron Pharm Inc Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof
US8003602B2 (en) * 2006-04-18 2011-08-23 Piramal Life Sciences Limited Antibacterial compounds
PE20080103A1 (es) 2006-05-31 2008-04-03 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
WO2008082562A2 (en) 2006-12-20 2008-07-10 Novartis Ag Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
CA2708793C (en) 2007-12-12 2016-06-21 Novartis Ag Aminothiazoles and their uses
WO2012062906A1 (en) 2010-11-11 2012-05-18 Instituto Biomar, S.A. Peptides as bioactive compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR960703410A (ko) 1996-08-17
AU679202B2 (en) 1997-06-26
DE69317058D1 (de) 1998-03-26
CA2151616A1 (en) 1994-07-07
JPH08504782A (ja) 1996-05-21
DK0675900T3 (da) 1998-03-09
ES2112517T3 (es) 1998-04-01
DE69317058T2 (de) 1998-06-10
WO1994014838A1 (en) 1994-07-07
EP0675900B1 (de) 1998-02-18
EP0675900A1 (de) 1995-10-11
AU5810894A (en) 1994-07-19
GR3026590T3 (en) 1998-07-31

Similar Documents

Publication Publication Date Title
NO20002434D0 (no) Oksazolidinonderivater og farmasøytiske preparater
ATE246192T1 (de) Ethyliden-derivate tricyclyscher carbapenems
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
BR0015722A (pt) Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas
BG101570A (bg) Производни на еритромицин а 9-0-оксим, притежаващи антибиотична активност
DE69317058D1 (de) Die antibiotika ge 37468 a, b und c
CA2037779A1 (en) Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
AU5643299A (en) Humic acid and its use in the treatment of various conditions
ES2113391T3 (es) Factor c2a de antibiotico ge 2270.
DE69216746D1 (de) Propanolamin-Cyclohexapeptide
SE8501532L (sv) Nya lekemedelskombinationer med synergistisk verkan och forfarande for deras framstellning
ES2094757T3 (es) Un factor megacariocitopoyetico.
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные
DE3775823D1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
DE69941459D1 (de) Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
ATE117725T1 (de) Antibiotikum ge1655-komplex und seine faktoren a,b und c.
DK627188D0 (da) Farmaceutisk komposition
SE7707274L (sv) Derivat av kinoxalin-1-4-dioxider och forfarande for framstellning derav
IT1216103B (it) Peptidi ad attivita' farmaceutica.
WO1997037631A3 (en) Chemotherapeutic veterinary drug containing oxytetracycline, sulfadimidine and neomycin
SE8502038L (sv) Nya lekemedelskompositioner och forfarande for deras framstellning